(NASDAQ: PODD) Insulet's forecast annual revenue growth rate of 15.38% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.06%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.76%.
Insulet's revenue in 2025 is $2,198,900,000.On average, 6 Wall Street analysts forecast PODD's revenue for 2025 to be $177,515,535,523, with the lowest PODD revenue forecast at $176,901,443,945, and the highest PODD revenue forecast at $179,104,179,035. On average, 9 Wall Street analysts forecast PODD's revenue for 2026 to be $206,584,671,593, with the lowest PODD revenue forecast at $198,422,095,399, and the highest PODD revenue forecast at $212,736,354,737.
In 2027, PODD is forecast to generate $238,319,820,870 in revenue, with the lowest revenue forecast at $225,587,378,676 and the highest revenue forecast at $249,479,102,035.